Abstract
Monitoring loss of striatal phosphodiesterase 10A (PDE10A) with [ <sup>18</sup> F]MNI-659 and PET: A biomarker of early Huntington disease (HD) progression. (I11-4A)
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
